Clinical Trials Browser

Phase 2 × Familial ependymoma × Everolimus × Clear all

NCT02155920 2024-05-08

Everolimus for Children With Recurrent or Progressive Ependymoma

Phase 2 Completed

11 enrolled 13 charts

Familial ependymoma, Ependymoma